Choline Deficiency and Hepatic Steatosis: Establishing the Metabolic Link
A landmark study by Buchman and colleagues published in Hepatology demonstrated that choline deficiency directly causes hepatic steatosis (fatty liver) in humans. The researchers studied patients receiving long-term parenteral nutrition without choline supplementation and documented the development of significant hepatic fat accumulation. Critically, intravenous choline supplementation reversed the steatosis, establishing a direct causal relationship between choline availability and hepatic lipid homeostasis. This study provided foundational evidence that choline is an essential nutrient for normal hepatic lipid export via VLDL (very low-density lipoprotein) assembly and secretion.
Citation: Buchman AL, Dubin MD, Moukarzel AA, et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology. 1995;22(5):1399-1403. PubMed PMID: 7590654
Choline Metabolism and Non-Alcoholic Fatty Liver Disease
A comprehensive review published in Biochimica et Biophysica Acta — Molecular Basis of Disease by Corbin and Zeisel examined the relationship between choline metabolism and non-alcoholic fatty liver disease (NAFLD). The authors detailed how choline serves as the precursor for phosphatidylcholine, which is required for VLDL assembly and hepatic triglyceride export. The review documented that inadequate choline intake — particularly common in certain populations — is associated with increased susceptibility to hepatic fat accumulation. The authors also noted that genetic polymorphisms affecting choline metabolism (particularly PEMT pathway variants) modulate individual requirements, establishing that choline’s role in hepatic lipid metabolism is both nutritionally and genetically regulated.
Citation: Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Current Opinion in Gastroenterology. 2012;28(2):159-165. doi:10.1097/MOG.0b013e32834e7b4b. PubMed PMID: 22134222
Carnitine Transport and Mitochondrial Fatty Acid Oxidation
A detailed review published in Biochimica et Biophysica Acta — Molecular Cell Research by Longo and colleagues examined the essential role of L-carnitine in mitochondrial fatty acid oxidation. The authors described how the mitochondrial inner membrane is impermeable to long-chain acyl-CoA molecules, and that L-carnitine conjugation via carnitine palmitoyltransferase I (CPT-I) is the obligatory step for fatty acid entry into the mitochondrial matrix for β-oxidation. The review detailed the carnitine shuttle system (CPT-I, carnitine-acylcarnitine translocase, and CPT-II) and documented that disruptions at any point in this transport chain result in impaired fatty acid oxidation and lipid accumulation.
Citation: Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta. 2016;1863(10):2422-2435. doi:10.1016/j.bbamcr.2016.01.023. PubMed PMID: 26828774
Myo-Inositol in Metabolic Syndrome: A Randomized Controlled Trial
Giordano and colleagues published a randomized controlled trial in Menopause evaluating the effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Participants receiving myo-inositol demonstrated significant improvements in serum insulin, HOMA-IR (homeostatic model assessment of insulin resistance), blood pressure, and serum lipid profiles compared to placebo. Notably, 20% of participants in the inositol group no longer met the diagnostic criteria for metabolic syndrome by the end of the study period. The authors attributed these effects to inositol’s role as a second messenger in insulin signaling pathways, where it participates in the phosphatidylinositol cycle and modulates glucose transporter translocation.
Citation: Giordano D, Corrado F, Santamaria A, et al. Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. Menopause. 2011;18(1):102-104. doi:10.1097/gme.0b013e3181e8e1b1. PubMed PMID: 20811299
Methionine in Methylation and Transsulfuration Pathways
A review published in the Journal of Nutrition by Finkelstein examined the metabolic pathways of methionine and their significance in cellular biochemistry. Methionine serves as the precursor for S-adenosylmethionine (SAMe), the universal methyl donor required for over 200 methylation reactions including DNA methylation, phospholipid synthesis, and neurotransmitter metabolism. Through the transsulfuration pathway, methionine also provides the sulfur atom for cysteine synthesis — and cysteine is the rate-limiting precursor for glutathione (GSH), the cell’s primary antioxidant defense system. This dual role in methylation and antioxidant synthesis positions methionine as a central node in cellular metabolism.
Citation: Finkelstein JD. Methionine metabolism in mammals. Journal of Nutritional Biochemistry. 1990;1(5):228-237. doi:10.1016/0955-2863(90)90070-2. PubMed PMID: 15539209
Reviewed for scientific accuracy — Chameleon Peptides Research Team. Last reviewed: March 2026.